期刊
CANCER RESEARCH
卷 82, 期 4, 页码 556-570出版社
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-21-1446
关键词
-
类别
资金
- National Science and Technology Major Project [2020ZX09201021]
- National Natural Science Foundation of China [81972471, 81730077, 82025026]
- Guangdong Basic and Applied Basic Research Foundation [2020A1515010115, 2019A1515110082]
- Guangdong province Science and Technology Plan Foundation [A2019259]
- Guangzhou Science and Technology Major Program [201704020131]
- Guangdong Science and Technology Department [2017B030314026]
- Sun Yat-sen University Clinical Research 5010 Program [2018007]
- Sun Yat-sen Clinical Research Cultivating Program [SYS-C-201801]
- Medical Artificial Intelligence Project of Sun Yat-sen Memorial Hospital [YXRGZN201902]
- China Postdoctoral Science Foundation [2020TQ0377]
This study identifies an epigenetic-driven NF kappa B/IL8 cascade initiated by a lncRNA, whose aberrant activation contributes to tumor metastasis and poor survival in patients with triple-negative breast cancer.
Aberrant activation of NF kappa B orchestrates a critical role in tumor carcinogenesis; however, the regulatory mechanisms underlying this activation are not fully understood. Here we report that a novel long noncoding RNA (lncRNA) Uc003xsl.1 is highly expressed in triple-negative breast cancer (TNBC) and correlates with poor outcomes in patients with TNBC. Uc003xsl.1 directly bound nuclear transcriptional factor NF kappa B-repressing factor (NKRF), subsequently preventing NKRF from binding to a specific negative regulatory element in the promoter of the NF kappa B-responsive gene IL8 and abolishing the negative regulation of NKRF on NF kappa B-mediated transcription of IL8. Activation of the NF kappa B/IL8 axis promoted the progression of TNBC. Trop2-based antibody-drug conjugates have been applied in clinical trials in TNBC. In this study, a Trop2-targeting, redox-responsive nano-particle was developed to systematically deliver Uc003xsl.1 siRNA to TNBC cells in vivo, which reduced Uc003xsl.1 expression and suppressed TNBC tumor growth and metastasis. Therefore, target-ing Uc003xsl.1 to suppress the NF kappa B/IL8 axis represents a prom-ising therapeutic strategy for TNBC treatment. Significance: These findings identify an epigenetic-driven NF kappa B/IL8 cascade initiated by a lncRNA, whose aberrant acti-vation contributes to tumor metastasis and poor survival in patients with triple-negative breast cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据